609 Results

People

  1. Lilja
    Lilja
  2. Vickers
    Vickers
  3. Scher
    Scher
  4. Eastham
    Eastham
  5. Scardino
    Scardino
  6. Zelefsky
    Zelefsky
  7. Kattan
    Kattan
  8. Carlsson
    Carlsson
  9. Kelly
    Kelly
  10. Slovin
    Slovin

Groups

  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)
  7. Department of Medicine (143)
  8. Solid Tumor Oncology Division (138)
  9. Genitourinary Oncology Service (135)
  10. Health Outcomes Research Group (133)
  1. "prostate-specific antigen"
Formats
  1. Journal Article (570)
  2. Editorial (8)
  3. Review (8)
  4. Conference Paper (6)
  5. Guidelines (5)
  6. Meeting Abstract (4)
  7. Book Section (3)
  8. Correspondence (3)
  9. Research Letter (2)
Groups
  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)

More Groups

People
  1. Hans Lilja (135)
  2. Peter Scardino (117)
  3. Andrew Vickers (98)
  4. Howard Scher (96)
  5. James Eastham (80)
  6. Michael Zelefsky (64)

More People

Years
  1. 2025 (3)
  2. 2024 (26)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Journal of Urology (69)
  2. European Urology (47)
  3. International Journal of Radiation Oncology, Biology, Physics (40)
  4. Journal of Clinical Oncology (39)
  5. Urology (36)
  6. Clinical Cancer Research (31)

More Publications

Publishers
  1. Elsevier Science, Inc. (162)
  2. Elsevier Inc. (72)
  3. Wiley Blackwell (64)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (39)
  6. John Wiley & Sons (29)

More Publishers

Results (609)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Addition of prostate volume and prostate-specific antigen density to Memorial Sloan Kettering Cancer Center prostate cancer nomograms
    Research Letter

    Tzeng, M.; Vertosick, E.; Basourakos, S. P.; Eastham, J. A.; Ehdaie, B.; Scardino, P. T.; Vickers, A. J.; Hu, J. C.
    European Urology Open Science (2021)

    Fulltext@MSK | Save
  • Concordance between response assessment using prostate-specific membrane antigen PET and serum prostate-specific antigen levels after systemic treatment in patients with metastatic castration resistant prostate cancer: A systematic review and meta-analysis
    Review

    Han, S.; Woo, S.; Kim, Y. I.; Lee, J. L.; Wibmer, A. G.; Schoder, H.; Ryu, J. S.; Vargas, H. A.
    Diagnostics (2021)

    Fulltext@MSK | Save
  • The GÖTEBORG prostate cancer screening 2 trial: A prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate
    Journal Article

    Kohestani, K.; Månsson, M.; Arnsrud Godtman, R.; Stranne, J.; Wallström, J.; Carlsson, S.; Hellström, M.; Hugosson, J.
    Scandinavian Journal of Urology (2021)

    Fulltext@MSK | Save
  • Early tolerance and tumor control outcomes with high-dose ultrahypofractionated radiation therapy for prostate cancer
    Journal Article

    Zelefsky, M. J.; Pinitpatcharalert, A.; Kollmeier, M.; Goldman, D. A.; McBride, S.; Gorovets, D.; Zhang, Z.; Varghese, M.; Happersett, L.; Tyagi, N.; more...
    European Urology Oncology (2020)

    Fulltext@MSK | Save
  • Screening for prostate cancer
    Review

    Carlsson, S. V.; Vickers, A. J.
    Medical Clinics of North America (2020)

    Fulltext@MSK | Save
  • Prespecified 4-kallikrein marker model at age 50 or 60 for early detection of lethal prostate cancer in a large population based cohort of asymptomatic men followed for 20 years
    Journal Article

    Vertosick, E. A.; Häggström, C.; Sjoberg, D. D.; Hallmans, G.; Johansson, R.; Vickers, A. J.; Stattin, P.; Lilja, H.
    Journal of Urology (2020)

    Fulltext@MSK | Save
  • (11)C-choline PET/CT in recurrent prostate cancer: Retrospective analysis in a large U.S. patient series
    Journal Article

    Michaud, L.; Touijer, K. A.; Mauguen, A.; Zelefsky, M. J.; Morris, M. J.; Lyashschenko, S. K.; Durack, J. C.; Humm, J. L.; Weber, W. A.; Schöder, H.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
    Journal Article

    Assel, M. J.; Ulmert, H. D.; Karnes, R. J.; Boorjian, S. A.; Hillman, D. W.; Vickers, A. J.; Klee, G. G.; Lilja, H.
    Prostate (2020)

    Fulltext@MSK | Save
  • Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?
    Journal Article

    Cavalcanti Viana, P. C.; Horvat, N.; dos Santos Júnior, V. R.; Lima, T. C.; Romão, D. S.; Cerri, L. M. O.; de Castro, M. G.; Vargas, H. A.; Miranda, J. A.; Leite, C. C.; more...
    International Brazilian Journal of Urology (2019)

    Fulltext@MSK | Save
  • The role of plasma microseminoprotein-beta in prostate cancer: An observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition
    Journal Article

    Smith Byrne, K.; Appleby, P. N.; Key, T. J.; Holmes, M. V.; Fensom, G. K.; Agudo, A.; Ardanaz, E.; Boeing, H.; Bueno-de-Mesquita, H. B.; Chirlaque, M. D.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save